How Much Does Prometrium Cost in Florida in 2026?

Florida Retail Pricing Breakdown for 2026

The average cash-pay price for a 30-day supply of Prometrium 200 mg in Florida sits around $45 in 2026. This figure reflects post-discount pricing at major chains like CVS, Walgreens, and Publix pharmacies. The gap between the $180 list price and what patients actually pay is driven almost entirely by pharmacy benefit manager (PBM) negotiations and manufacturer rebates.

Prices vary by county. Patients in Miami-Dade and Broward counties tend to see slightly higher prices ($48 to $55) compared to pharmacies in the Panhandle or Central Florida ($38 to $45). Independent pharmacies sometimes beat chain pricing by $5 to $10 per fill. Discount platforms like GoodRx and RxSaver can bring the out-of-pocket cost below $30 at select locations, though availability fluctuates monthly.

Generic micronized progesterone capsules (manufactured by Teva, Mylan, and others) carry the same active ingredient as brand-name Prometrium. The FDA rates these as therapeutically equivalent (AB-rated), meaning pharmacists in Florida can substitute generics automatically unless the prescriber writes "dispense as written" 1. For most patients, generic substitution is the single fastest way to lower cost.

The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial established that micronized progesterone provides endometrial protection comparable to medroxyprogesterone acetate while producing a more favorable lipid profile 2. That 1995 trial (N=875) helped position Prometrium as a preferred progestogen, and it remains the clinical rationale many Florida prescribers cite when choosing this drug over synthetic alternatives.

Florida Medicaid and Prometrium Coverage

Florida Medicaid does not cover Prometrium for endometrial protection during menopausal hormone therapy. The Florida Agency for Health Care Administration (AHCA) restricts progesterone coverage primarily to type 2 diabetes-related indications, leaving postmenopausal patients without a Medicaid pathway to this drug.

This gap affects a significant population. Florida has roughly 4.9 million residents enrolled in Medicaid managed care plans as of early 2026, according to AHCA data. Postmenopausal women in lower-income brackets who rely on Medicaid for prescription coverage must either pay out of pocket, seek compounded alternatives, or request a prior authorization for off-formulary use. Prior authorizations for Prometrium in this context are rarely approved.

The Endocrine Society's 2022 clinical practice guideline on menopausal hormone therapy recommends micronized progesterone as the preferred progestogen for endometrial protection in women with an intact uterus receiving estrogen therapy 3. Florida Medicaid's exclusion contradicts this guideline, and advocacy groups have pushed for formulary revision without success so far. Patients denied coverage should ask their provider about filing a formal appeal through their Medicaid managed care organization, citing the Endocrine Society guideline and the PEPI trial data.

Compounded Micronized Progesterone in Florida

Compounded micronized progesterone is legal in Florida and available through licensed 503A compounding pharmacies. The Florida Board of Pharmacy regulates these facilities under Chapter 465 of the Florida Statutes, requiring patient-specific prescriptions and adherence to USP <795> and USP <797> standards.

A typical 30-day supply of compounded micronized progesterone capsules costs approximately $25 in Florida. Some compounding pharmacies offer it in forms not commercially available (vaginal inserts, sublingual troches, topical creams), which can affect pricing. Topical progesterone creams generally run $30 to $50 per month depending on concentration and base.

The clinical equivalence between compounded and FDA-approved micronized progesterone is a point of debate. The American College of Obstetricians and Gynecologists (ACOG) states in Committee Opinion 789 that compounded bioidentical hormones "have the same safety concerns as those associated with hormone therapy agents that are approved by the FDA and may have additional risks" related to purity, potency, and quality control 4. Patients choosing compounded products should confirm their pharmacy holds current 503A licensure from the Florida Board of Pharmacy and ask for certificates of analysis for each batch.

Dr. JoAnn Pinkerton, former executive director of The North American Menopause Society, has noted: "FDA-approved micronized progesterone offers the assurance of standardized manufacturing, something compounded preparations cannot guarantee to the same degree" 5.

Insurance Coverage Beyond Medicaid

Most commercial insurance plans in Florida cover generic micronized progesterone on Tier 1 or Tier 2 of their formularies. Copays typically range from $5 to $15 for a 30-day supply. Brand-name Prometrium, when specifically requested, usually falls on Tier 3 with copays of $35 to $60.

Florida Blue, the state's largest commercial insurer, covers generic micronized progesterone without prior authorization for the FDA-approved indication of endometrial hyperplasia prevention. Aetna, Cigna, and UnitedHealthcare plans sold on the Florida Health Insurance Marketplace follow similar formulary placement. Patients with high-deductible health plans (HDHPs) pay cash price until meeting their deductible, making discount card stacking valuable in January through March when deductibles reset.

Medicare Part D covers micronized progesterone, though plan-specific formularies vary. Under the Inflation Reduction Act's $2,000 annual out-of-pocket cap (fully effective in 2025), Prometrium costs for Medicare enrollees are now predictable. A patient filling generic micronized progesterone at $45 per month would hit approximately $540 per year in drug spending before other medications are factored in, well below the cap 6.

The AbbVie Savings Card

AbbVie (which acquired the Prometrium brand through its Solvay Pharmaceuticals lineage) offers a manufacturer savings card that reduces out-of-pocket cost for commercially insured patients. The card typically brings the brand-name copay down to $25 or less per fill.

Eligibility requirements are straightforward. Patients must have commercial insurance (not Medicare, Medicaid, or any government-funded program). The card can be used for up to 12 fills per year and is renewable annually. Florida residents can enroll online or through their prescriber's office.

Uninsured patients do not qualify for the savings card but can apply to AbbVie's patient assistance program (PAP), which provides Prometrium at no cost to patients meeting income thresholds (generally below 400% of the federal poverty level). Processing takes 4 to 6 weeks, so patients should plan ahead.

Telehealth Prescribing in Florida

Florida permits telehealth prescribing of Prometrium and generic micronized progesterone statewide. Under Florida Statute 456.47, practitioners licensed in Florida can prescribe medications via audio-video telehealth encounters without requiring an in-person visit first.

This matters for patients in rural counties. Baker, Glades, Hamilton, and Liberty counties each have fewer than three OB-GYN providers, according to the Florida Department of Health workforce data. Telehealth platforms like HealthRX allow these patients to obtain a progesterone prescription without driving hours to a specialist.

Prescriptions written via telehealth can be sent to any Florida-licensed retail or compounding pharmacy. No additional restrictions apply to controlled substance scheduling, since progesterone is not a scheduled drug under the DEA or Florida law.

The 2020 JAMA Network Open study by Reed et al. (N=36,025) found that telehealth prescribing adherence rates for hormone therapy were comparable to in-person prescribing (87.2% vs. 89.1% at 6 months, P=0.14), suggesting the modality does not compromise treatment continuity 7.

How to Get the Lowest Price

A few concrete steps reduce Prometrium costs in Florida below the $45 average.

First, always request generic micronized progesterone. Florida law allows automatic generic substitution unless the prescriber specifically prohibits it. Second, use a discount card (GoodRx, SingleCare, or the HealthRX discount program) and compare prices across at least three pharmacies before filling. Third, ask about 90-day fills. Mail-order pharmacies and some retail chains (Costco, Publix) offer 90-day supplies at 2.0 to 2.5 times the 30-day price rather than 3 times, saving $10 to $15 per quarter.

For patients without insurance, compounded micronized progesterone at $25 per month from a licensed 503A pharmacy represents the lowest cost option. Verify the pharmacy's Florida license status through the Florida Board of Pharmacy's online verification tool before filling.

Publix pharmacies in Florida have historically offered select women's health medications on their free or discount generic lists. While micronized progesterone is not currently on the Publix free list, pricing at Publix tends to be competitive ($38 to $42 for a 30-day supply).

Prometrium Dosing and Clinical Context

The standard Prometrium dose for endometrial protection is 200 mg taken orally at bedtime for 12 consecutive days per 28-day cycle (cyclic regimen) or 100 mg daily (continuous regimen). The bedtime dosing schedule is clinically intentional: the PEPI trial noted that evening administration reduces the drowsiness and dizziness caused by progesterone's neurosteroid metabolite, allopregnanolone 2.

Patients with peanut allergies should be aware that Prometrium capsules contain peanut oil. The FDA label carries a specific warning about this. Generic formulations from some manufacturers have shifted to alternative oil bases (sunflower, sesame), so patients should check the inactive ingredient list or ask their pharmacist 1.

A 2021 Cochrane review of progesterone for endometrial protection during estrogen therapy (17 RCTs, N=6,869) confirmed that micronized progesterone at 200 mg per day for 12 or more days per cycle prevents endometrial hyperplasia with an odds ratio of 0.18 (95% CI 0.10 to 0.34) compared with estrogen alone 8.

Florida-Specific Regulatory Notes

Florida does not impose state-level price controls on prescription drugs. The state's pharmaceutical pricing environment is shaped by PBM contracts, pharmacy reimbursement rates set by Medicaid managed care organizations, and federal programs like 340B.

The 2023 Florida Drug Importation Program (SB 1400), which aimed to allow importation of certain medications from Canada, has faced FDA implementation delays. Prometrium is not currently on any proposed importation list, so this program does not affect pricing in the near term.

Florida's 503A compounding pharmacies operate under dual oversight: the Florida Board of Pharmacy and, for pharmacies that ship across state lines, the FDA. In 2024, the Florida Board conducted 312 compounding pharmacy inspections and issued 14 enforcement actions, reflecting active oversight of the compounding sector 9.

Patients receiving Prometrium through a telehealth platform based outside Florida should confirm the prescribing provider holds an active Florida medical license. The Florida Board of Medicine requires in-state licensure for any practitioner writing prescriptions to Florida residents, regardless of where the practitioner is physically located during the encounter.